Martin A Case

This inventor holds 14 USPTO granted patents and 7 published patent applications and 4 EPO patents. Top assignees: Janssen Pharmaceutica Nv, Janssen Sciences Ireland Unlimited Company. Active years: 2019-2024.

USPTO Granted Patents = 14 (Patent Applications = 7)

% Patents Active = 100.0

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 10.8

ph-index = 2

Forward Citations = 20(Granted Patents)

Company Filing History:

13 out of 2,100

Janssen Pharmaceutica Nv

patents

1 out of 64

Janssen Sciences Ireland Unlimited Company

patents

Years Active: 2019-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12134636 - Immunoglobulins and uses thereof (2024-11-05),

2. 11780900 - Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof (2023-10-10),

3. 11767354 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2023-09-26),

4. 11732019 - Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2023-08-22),

5. 11591379 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2023-02-28),

6. 11401315 - Immunoglobulins and uses thereof (2022-08-02),

7. 10968265 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2021-04-06),

8. 10968264 - Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2021-04-06),

9. 10961293 - Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2021-03-30),

10. 10875902 - Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof (2020-12-29),

11. 10858413 - Immunoglobulins and uses thereof (2020-12-08),

12. 10787495 - Immunoglobulins and uses thereof (2020-09-29),

13. 10640544 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors (2020-05-05),

14. 10428134 - Immunoglobulins and uses thereof (2019-10-01),

Title: The Innovative Mind of Martin A Case

Introduction: Martin A Case is a renowned inventor based in San Diego, CA (US) known for his groundbreaking contributions to various fields.

Latest Patents: Martin A Case holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Martin A Case has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Martin A Case has collaborated with leading companies, research institutions, and universities to bring his ideas to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Martin A Case's passion for innovation and his relentless drive to create have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to think outside the box.